Treating unhappiness - Society needs palliative psychopharmacology

British Journal of Psychiatry

Volumn 185, Issue SEPT., 2004, Pages 194-195

  Charlton, Bruce G ^a   McKenzie, Kwame ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; OPIATE; PARACETAMOL; PSYCHOTROPIC AGENT;

BACKACHE; HAPPINESS; HEADACHE; HUMAN; MENTAL DISEASE; PALLIATIVE THERAPY; PSYCHIATRIST; PSYCHIATRY; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; PUBLIC HEALTH; QUALITY OF LIFE; REVIEW;

EID: 4444274339     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.185.3.194     Document Type: Review

References (6)

1. Charlton, B. (2000) Psychiatry and the Human Condition. Abingdon: Radcliffe Medical.
2. Charlton, B. G. (2001) Personal freedom or public health? In Medicine and Humanity (ed. M. Marinker), pp. 55-69. London: King's Fund.
3. Charlton, B. G. (2003) Palliative psychopharmacology: a putative speciality to optimise the subjective quality of life. QJM, 96, 375-378.
4. Healy, D. (2002) The Creation of Psychopharmacology. Cambridge, MA: Harvard University Press.
5. Kramer, P. (1994) Listening to Prozac, London: Fourth Estate.
6. Whitaker, R. (2002) Mad in America. New York: Perseus.